We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 131% below its sector, cheaper than its peers on earnings.
Operating both domestically within the People's Republic of China and across international markets, Beijing SL Pharmaceutical Co., Ltd. is a biopharmaceutical firm dedicated to the research, development, manufacturing, and commercialization of genetic engineering-based pharmaceuticals and associated medicinal products. Its extensive portfolio of finished pharmaceutical products encompasses a diverse range of medications, including but not limited to, temozolomide, arsenic trioxide, lenalidomide, docetaxel, paclitaxel, recombinant human granulocyte colony-stimulating factor (filgrastim), recombinant human interleukin-11, recombinant human interleukin-2, thymopentin, vinorelbine bitartrate, hydroxyl-camptothecine, nimustine hydrochloride, asparaginase, PEG L-asparaginase, calcium foliate, recombinant human basic fibroblast growth factor, ciclosporin, mycophenolate mofetil dispersible, ornidazole, adefovir dipivoxil, levofloxacin hydrochloride, azithromycin, ribavirin, tenofovir disoproxil fumarate, valacylovir hydrochloride, lysozyme, stavudine, tropisetron hydrochloride, granisetron hydrochloride, omeprazole, ademetionine 1,4-butanedisulfonate, glutathione, enoxaparin sodium, coenzyme complex, ginkgo biloba extract, simvastatin, telmisartan, naftopidil, nicergoline, zaleplon, cytidine disodium triphosphate, febuxostat, risedronate sodium, loratadine dispersible, somatostatin, octreotide acetate, calcitonin (salmon), the combination of paracetamol and tramadol hydrochloride, and etodolac. Furthermore, the company supplies active pharmaceutical ingredients (APIs). Established in Beijing, People's Republic of China, in 1994, the enterprise initially operated under the name Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd. before officially adopting its current designation, Beijing SL Pharmaceutical Co., Ltd., in 1998.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 002038.SZ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
